Annual Working Capital
$125.89 M
-$60.21 M-32.35%
31 December 2023
Summary:
Athira Pharma annual working capital is currently $125.89 million, with the most recent change of -$60.21 million (-32.35%) on 31 December 2023. During the last 3 years, it has fallen by -$62.04 million (-33.01%). ATHA annual working capital is now -49.95% below its all-time high of $251.51 million, reached on 31 December 2021.ATHA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$54.25 M
-$25.55 M-32.02%
30 September 2024
Summary:
Athira Pharma quarterly working capital is currently $54.25 million, with the most recent change of -$25.55 million (-32.02%) on 30 September 2024. Over the past year, it has dropped by -$95.63 million (-63.80%). ATHA quarterly working capital is now -82.33% below its all-time high of $307.07 million, reached on 31 March 2021.ATHA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -32.4% | -63.8% |
3 y3 years | -33.0% | -76.4% |
5 y5 years | +2810.7% | - |
ATHA Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -50.0% | at low | -79.1% | at low |
5 y | 5 years | -50.0% | >+9999.0% | -82.3% | +6016.2% |
alltime | all time | -50.0% | >+9999.0% | -82.3% | +6016.2% |
Athira Pharma Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $54.25 M(-32.0%) |
June 2024 | - | $79.80 M(-22.6%) |
Mar 2024 | - | $103.04 M(-18.2%) |
Dec 2023 | $125.89 M(-32.4%) | $125.89 M(-16.0%) |
Sept 2023 | - | $149.88 M(-12.1%) |
June 2023 | - | $170.47 M(-1.3%) |
Mar 2023 | - | $172.75 M(-7.2%) |
Dec 2022 | $186.10 M | $186.10 M(-14.9%) |
Sept 2022 | - | $218.71 M(-11.2%) |
June 2022 | - | $246.17 M(-5.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $259.68 M(+3.3%) |
Dec 2021 | $251.51 M(+33.8%) | $251.51 M(+9.5%) |
Sept 2021 | - | $229.61 M(-18.8%) |
June 2021 | - | $282.86 M(-7.9%) |
Mar 2021 | - | $307.07 M(+63.4%) |
Dec 2020 | $187.93 M(>+9900.0%) | $187.93 M(-16.4%) |
Sept 2020 | - | $224.71 M(+182.8%) |
June 2020 | - | $79.46 M(+8858.4%) |
Dec 2019 | $887.00 K(-79.5%) | $887.00 K |
Dec 2018 | $4.33 M | - |
FAQ
- What is Athira Pharma annual working capital?
- What is the all time high annual working capital for Athira Pharma?
- What is Athira Pharma annual working capital year-on-year change?
- What is Athira Pharma quarterly working capital?
- What is the all time high quarterly working capital for Athira Pharma?
- What is Athira Pharma quarterly working capital year-on-year change?
What is Athira Pharma annual working capital?
The current annual working capital of ATHA is $125.89 M
What is the all time high annual working capital for Athira Pharma?
Athira Pharma all-time high annual working capital is $251.51 M
What is Athira Pharma annual working capital year-on-year change?
Over the past year, ATHA annual working capital has changed by -$60.21 M (-32.35%)
What is Athira Pharma quarterly working capital?
The current quarterly working capital of ATHA is $54.25 M
What is the all time high quarterly working capital for Athira Pharma?
Athira Pharma all-time high quarterly working capital is $307.07 M
What is Athira Pharma quarterly working capital year-on-year change?
Over the past year, ATHA quarterly working capital has changed by -$95.63 M (-63.80%)